NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

** HEALTH RESEARCH SHOWCASE THURSDAY 29 MAY 2025 **

News

You are here: Home > Gene and Cell Therapy > MDS Patient Support Group learn more about treatment of condition

MDS Patient Support Group learn more about treatment of condition

13 October 2017 · Listed under Gene and Cell Therapy, Molecular Diagnostics

Patients and relatives affected by Myelodysplastic Syndromes (MDS) have visited the MRC Weatherall Institute of Molecular Medicine (WIMM) at the John Radcliffe Hospital to find out more about advances in treating the condition.

The members of the Oxford and Thames Valley MDS Patient Support Group visited the WIMM Friday 29 September.

MDS are a group of bone marrow disorders in which the bone marrow does not produce enough healthy blood cells.

The visit was hosted by clinician scientist Dr Lynn Quek (pictured) and members of Prof Paresh Vyas’s research team at the MRC Molecular Haematology Unit, who are members of the Radcliffe Department of Medicine. Their research is supported by the NIHR Oxford Biomedical Research Centre.

The visit started with a series of short presentations on the research into haematological cancers currently being conducted at the MRC WIMM, including efforts to improve patient care and recent advances in genomics and stem cell biology. This was followed by a lively question and answer session, and a tour of research facilities.

Nurse Kirsty Crozier, who leads the patient group said: “These visits are vital in helping patients and relatives fully understand, feel informed and appreciate where advances come from in relation to their disease, even if they are not yet feeling their direct impact.”

Feedback from the visit was very positive: “The best part for me was undoubtedly the input from Dr Quek and her colleagues, which fascinated both my daughter and me”, said one of the patients “We talked of little else for the rest of the day and still do! The laboratory visit was also most interesting.”

The researchers involved also benefited greatly from this experience, as Dr Quek explained: “Visits such as these are an opportunity for research scientists to exchange ideas with patients and involve them in the process”.

← Researchers thank Bloodwise fundraisers for funding critical leukaemia trial
Oxford Centre for Haematology launched →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre